Long-term effect of interferon-free treatment in subjects with hepatitis C virus (HCV)-related decompensated cirhosis

Long-term effect of interferon-free treatment in subjects with hepatitis C virus (HCV)-related decompensated cirhosis - DAA for decompensatd cirrhosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034735

Enrollment

102

Registered

2018-11-01

Start date

2018-10-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

decompensated cirrhosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients in clinical trial of Velpatasvir/Sofosbuvir with or without ribavirin in Japan

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Child-Pugh score, MELD score HCC occurence rate	—

Secondary

Measure	Time frame
Survival rate Incidence rate of gastroesophageal varix rupture Factors associated with improvement in liver function Factors associated with HCC occurrence Factors associated with survival Factors associated with gastroesophageal varix rupture	—

Countries

Japan

Contacts

Public ContactYuki Tahata

Osaka University Graduate School of Medicine Gastroenterology and Hepatology

yuki.tahata@gh.med.osaka-u.ac.jp06-6879-3621

Outcome results